411 related articles for article (PubMed ID: 12746363)
1. Risk factors for pediatric human immunodeficiency virus-related malignancy.
Pollock BH; Jenson HB; Leach CT; McClain KL; Hutchison RE; Garzarella L; Joshi VV; Parmley RT; Murphy SB
JAMA; 2003 May; 289(18):2393-9. PubMed ID: 12746363
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
3. Significance of Epstein-Barr virus (HHV-4) and CMV (HHV-5) infection among subtype-C human immunodeficiency virus-infected individuals.
Sachithanandham J; Kannangai R; Pulimood SA; Desai A; Abraham AM; Abraham OC; Ravi V; Samuel P; Sridharan G
Indian J Med Microbiol; 2014; 32(3):261-9. PubMed ID: 25008818
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men.
Scaggiante R; Andreis S; Basso M; Franchin E; Franzetti M; Del Vecchio C; Torti C; Mengoli C; Cruciani M; Sarmati L; Palù G; Parisi SG
J Med Virol; 2016 Jul; 88(7):1211-21. PubMed ID: 26636290
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.
Kahn JA; Rudy BJ; Xu J; Kapogiannis B; Secord E; Gillison M
J Med Virol; 2016 Nov; 88(11):1944-52. PubMed ID: 27096166
[TBL] [Abstract][Full Text] [Related]
7. Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.
Smith DM; Nakazawa M; Freeman ML; Anderson CM; Oliveira MF; Little SJ; Gianella S
Clin Infect Dis; 2016 Dec; 63(11):1517-1524. PubMed ID: 27601222
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus load in children infected with human immunodeficiency virus type 1 in Uganda.
Petrara MR; Penazzato M; Massavon W; Nabachwa S; Nannyonga M; Mazza A; Gianesin K; Del Bianco P; Lundin R; Sumpter C; Zanchetta M; Giaquinto C; De Rossi A
J Infect Dis; 2014 Aug; 210(3):392-9. PubMed ID: 24550442
[TBL] [Abstract][Full Text] [Related]
9. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma.
Van Baarle D; Wolthers KC; Hovenkamp E; Niesters HG; Osterhaus AD; Miedema F; Van Oers MH
J Infect Dis; 2002 Aug; 186(3):405-9. PubMed ID: 12134237
[TBL] [Abstract][Full Text] [Related]
10. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME
J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus viral load in human immunodeficiency virus-positive patients with reactive hemophagocytic syndrome.
Boisseau M; Lambotte O; Galicier L; Lerolle N; Marzac C; Aumont C; Coppo P; Fardet L
Infect Dis (Lond); 2015 Jun; 47(6):423-7. PubMed ID: 25746607
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
[TBL] [Abstract][Full Text] [Related]
13. Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus.
Giron LB; Ramos da Silva S; Barbosa AN; Monteiro de Barros Almeida RA; Rosário de Souza Ld; Elgui de Oliveira D
J Med Virol; 2013 Dec; 85(12):2110-8. PubMed ID: 24014234
[TBL] [Abstract][Full Text] [Related]
14. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR.
Dehee A; Asselot C; Piolot T; Jacomet C; Rozenbaum W; Vidaud M; Garbarg-Chenon A; Nicolas JC
J Med Virol; 2001 Nov; 65(3):543-52. PubMed ID: 11596092
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy.
Ling PD; Vilchez RA; Keitel WA; Poston DG; Peng RS; White ZS; Visnegarwala F; Lewis DE; Butel JS
Clin Infect Dis; 2003 Nov; 37(9):1244-9. PubMed ID: 14557970
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
Katlama C; Ingrand D; Loveday C; Clumeck N; Mallolas J; Staszewski S; Johnson M; Hill AM; Pearce G; McDade H
JAMA; 1996 Jul; 276(2):118-25. PubMed ID: 8656503
[TBL] [Abstract][Full Text] [Related]
17. Blood Epstein-Barr virus DNA load and risk of progression to AIDS-related systemic B lymphoma.
Leruez-Ville M; Seng R; Morand P; Boufassa F; Boue F; Deveau C; Rouzioux C; Goujard C; Seigneurin JM; Meyer L
HIV Med; 2012 Sep; 13(8):479-87. PubMed ID: 22414000
[TBL] [Abstract][Full Text] [Related]
18. HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts.
Gasser O; Bihl FK; Wolbers M; Loggi E; Steffen I; Hirsch HH; Günthard HF; Walker BD; Brander C; Battegay M; Hess C;
PLoS Med; 2007 Mar; 4(3):e96. PubMed ID: 17388662
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus genome load is increased by therapeutic vaccination in HIV-l carriers, and further enhanced in patients with a history of symptomatic primary infection.
Friis AM; Akerlund B; Gyllensten K; Aleman A; Bratt G; Sandström E; Ernberg I
Vaccine; 2012 Sep; 30(42):6093-8. PubMed ID: 22863659
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors for betaherpesvirus DNAemia in children >3 weeks and <2 years of age admitted to a large referral hospital in sub-Saharan Africa.
Tembo J; Kabwe M; Chilukutu L; Chilufya M; Mwaanza N; Chabala C; Zumla A; Bates M
Clin Infect Dis; 2015 Feb; 60(3):423-31. PubMed ID: 25352585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]